gemcitabine has been researched along with Leukemia, Myeloid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Advani, AS; Ali-Osman, F; Barker, A; Beaven, A; Copelan, E; de Castro, CM; Diehl, LF; Kalaycio, M; Moore, JO; Rizzieri, DA; Rybicki, L; Sekeres, MA; Shadman, M; Sobecks, R; Talea, P | 1 |
| Adams, DJ; Colvin, OM; Flowers, JL; Rizzieri, DA; Shanks, RH | 1 |
| Braess, J; Hiddemann, W; Jahns-Streubel, G; Kern, W; Keye, S; Schleyer, E; Unterhalt, M; Wegendt, C | 1 |
| Dumontet, C; Galmarini, CM; Mackey, JR | 1 |
| Achanta, G; Feng, L; Huang, P; Pelicano, H; Plunkett, W | 1 |
| Plunkett, W; Xu, YZ | 1 |
| Bouffard, DY; Momparler, LF; Momparler, RL | 1 |
1 review(s) available for gemcitabine and Leukemia, Myeloid
| Article | Year |
|---|---|
Nucleoside analogues: mechanisms of drug resistance and reversal strategies.
Topics: 2-Chloroadenosine; 5'-Nucleotidase; Acute Disease; Animals; Antimetabolites, Antineoplastic; Arabinonucleosides; Biological Transport; Carrier Proteins; Cytarabine; Cytidine Deaminase; Cytosine; Deoxyadenosines; Deoxycytidine; Deoxycytidine Kinase; Dioxolanes; DNA Repair; DNA Replication; DNA-Directed DNA Polymerase; Drug Resistance, Neoplasm; Gemcitabine; Hematopoietic Cell Growth Factors; Humans; Leukemia, Myeloid; Lymphoproliferative Disorders; Neoplastic Stem Cells; Nucleosides; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Remission Induction; Ribonucleotide Reductases; Vidarabine | 2001 |
1 trial(s) available for gemcitabine and Leukemia, Myeloid
| Article | Year |
|---|---|
A Phase II trial of gemcitabine and mitoxantrone for patients with acute myeloid leukemia in first relapse.
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Deoxycytidine; Drug Resistance, Multiple; Equilibrative-Nucleoside Transporter 2; Female; Fever; Gemcitabine; Gene Expression Regulation, Leukemic; Glutathione S-Transferase pi; Humans; Immunohistochemistry; Infusions, Intravenous; K562 Cells; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Multidrug Resistance-Associated Proteins; Recurrence; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction; Survival Analysis; U937 Cells | 2010 |
5 other study(ies) available for gemcitabine and Leukemia, Myeloid
| Article | Year |
|---|---|
Preclinical evaluation of gemcitabine combination regimens for application in acute myeloid leukemia.
Topics: Acute Disease; Antineoplastic Agents; Apoptosis; Camptothecin; Caspase 3; Caspase 7; Caspases; Cell Cycle; Chlorambucil; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation, Preclinical; Drug Interactions; Enzyme Activation; Flow Cytometry; Gemcitabine; Humans; Irinotecan; Leukemia, Myeloid; Mitoxantrone; Paclitaxel; U937 Cells; Vidarabine | 2005 |
Successful modulation of high-dose cytosine arabinoside metabolism in acute myeloid leukaemia by haematopoietic growth factors: no effect of ribonucleotide reductase inhibitors fludarabine and gemcitabine.
Topics: Arabinofuranosylcytosine Triphosphate; Cytarabine; Deoxycytidine; Deoxycytidine Kinase; Drug Administration Schedule; Enzyme Inhibitors; Gemcitabine; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Ribonucleotide Reductases; Vidarabine | 2000 |
Interaction of p53 and DNA-PK in response to nucleoside analogues: potential role as a sensor complex for DNA damage.
Topics: Antigens, Nuclear; Antimetabolites, Antineoplastic; Apoptosis; Binding, Competitive; Deoxycytidine; DNA Damage; DNA Helicases; DNA Repair; DNA Replication; DNA-Activated Protein Kinase; DNA-Binding Proteins; DNA, Neoplasm; Gemcitabine; Humans; Ku Autoantigen; Leukemia, Myeloid; Nuclear Proteins; Phosphorylation; Protein Serine-Threonine Kinases; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |
Modulation of deoxycytidylate deaminase in intact human leukemia cells. Action of 2',2'-difluorodeoxycytidine.
Topics: Antimetabolites, Antineoplastic; Carbon Radioisotopes; Cell Extracts; Chromatography, High Pressure Liquid; Cytidine Deaminase; DCMP Deaminase; Deoxycytidine; Deoxycytosine Nucleotides; Gemcitabine; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Thymine Nucleotides; Tumor Cells, Cultured | 1992 |
Comparison of antineoplastic activity of 2',2'-difluorodeoxycytidine and cytosine arabinoside against human myeloid and lymphoid leukemic cells.
Topics: Antimetabolites, Antineoplastic; Cell Division; Cytarabine; Deoxycytidine; DNA, Neoplasm; Gemcitabine; Humans; Kinetics; Leukemia, Experimental; Leukemia, Lymphoid; Leukemia, Myeloid; Phenotype; Tumor Cells, Cultured | 1991 |